Skip to main content
Log in

Dextrometorphan in molybdenum cofactor deficiency

  • Letters To The Editors
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abbreviations

DM :

dextromethorphan

MCD :

molybdenum cofactor deficiency

NMDA :

N-methyl-D-aspartate

References

  1. Ferkany JW, Borosky SA, Clissold DB, Pontecorvo J (1988) Dextromethorphan inhibits NMDA-induced convulsion. Eur J Pharmacology 151: 151–154

    Google Scholar 

  2. Johnson JL, Wadman SK (1988) Molydenum cofactor deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 1463–1475

    Google Scholar 

  3. Olney JW, Misra CH, Gubareff T de (1975) Cysteine-S-sulfate: brain damaging metabolite in sulfite oxidase deficiency. J Neuropathol Exp Neurol 34: 167–177

    Google Scholar 

  4. Schmitt B, Steinmann B, Gitzelmann R, Thun-Hohenstein L, Mascher H, Dumermuth G (1993) Nonketotic hyperglycinemia: clinical and electrophysiologic effects of dextromethorphan, an antagonist of the NMDA receptor. Neurology 43: 421–424

    Google Scholar 

  5. Schuierer G, Kurlemann G, Bick U, Stephani U (1995) Molybdenum cofactor deficiency: CT and MR findings. Neuropediatrics 26: 51–54

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kurlemann, G., Debus, O. & Schuierer, G. Dextrometorphan in molybdenum cofactor deficiency. Eur J Pediatr 155, 422–423 (1996). https://doi.org/10.1007/BF01955280

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01955280

Keywords

Navigation